logo

For the Inventor, By the Inventor

Exton, PA, United States of America

Denton W Hoyer

This inventor holds 9 USPTO granted patents. Top assignees: Vertex Pharmaceuticals, Inc., Sanofi, Sanofi Winthrop Inc.. Active years: 1996-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denton W Hoyer. Retrieved from https://idiyas.com/inventor/denton-w-hoyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 88.9

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 78(Granted Patents)


Company Filing History:

goldMedal5 out of 1,168 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal2 out of 1,547 
 
Sanofi
 patents
bronzeMedal1 out of 16 
 
Sanofi Winthrop Inc.
 patents
4. 1 out of 206 
 
Sterling Winthrop Inc.
 patents

Years Active: 1996-2006

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6995261 - 4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors (2006-02-07),
2. 6624166 - Pyridazines as interleukin-1&bgr; converting enzyme inhibitors (2003-09-23),
3. 6576614 - Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors (2003-06-10),
4. 6121266 - Pyridazines as interleukin-1.beta. converting enzyme inhibitors (2000-09-19),
5. 5985838 - Peptide analogs as irreversible interleukin-1.beta. protease inhibitors (1999-11-16),
6. 5677283 - .alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. converting (1997-10-14),
7. 5661020 - Low diol polyalkylene oxide biologically active proteinaceous substances (1997-08-26),
8. 5585357 - Heteroaryloxymethyl ketones as interleukin-1.beta.converting enzyme (1996-12-17),
9. 5532150 - Low diol polyalkylene oxide biologically active proteinaceous substances (1996-07-02),

Sure, here is the article about inventor Denton W Hoyer:

Title: Exploring the Innovations of Denton W Hoyer

Introduction:

Denton W Hoyer, a prolific inventor based in Exton, PA, has made significant contributions to the field of pharmaceuticals with a total of 9 patents to his name. Known for his groundbreaking work, Hoyer continues to push the boundaries of scientific discovery in the realm of medicinal chemistry.

Latest Patents:

Among his latest patents is the development of 4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors. These compounds, represented by the formula (I), have shown promising results in inhibiting interleukin-1β conversion, paving the way for potential therapeutic applications in treating various diseases.

Career Highlights:

Hoyer has been associated with esteemed companies such as Vertex Pharmaceuticals, Inc. and Sanofi, where he has showcased his expertise in drug development and pharmaceutical research. His innovative approach and dedication to advancing medical treatments have earned him recognition in the scientific community.

Collaborations:

Throughout his career, Hoyer has collaborated with accomplished individuals in the field, including Roland Ellwood Dolle and Stanley J Schmidt. Together, they have synergized their knowledge and skills to drive forward groundbreaking projects and bring novel concepts to fruition.

Conclusion:

In conclusion, Denton W Hoyer stands as a visionary inventor whose work exemplifies excellence and innovation in pharmaceutical research. With a trail of patents and a track record of successful collaborations, Hoyer continues to shape the future of medicine with his pioneering discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…